Kura Oncology (KURA) Interest Coverage Ratio (2010 - 2026)
Kura Oncology's (KURA) quarterly Interest Coverage Ratio came in at 9.98 in Q1 2026, up 93.83% year-on-year from 5.15 in Q1 2025, and up 95.72% on a QoQ basis from 232.9 in Q4 2025.
Kura Oncology (KURA) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Kura Oncology (KURA) has 8 years of Interest Coverage Ratio data on file, last reported at 9.98 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 93.83% year-over-year to 9.98 in Q1 2026; TTM through Mar 2026 was 34.69, a 305.79% decrease from a year earlier, with the FY2025 full-year figure at 0.83, down 20.44% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 9.98, up from 232.9 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for KURA reached as high as 486.16 in Q4 2024 and fell as low as 232.9 in Q4 2025.
- Historically, Interest Coverage Ratio has averaged 44.12 across 3 years, with a median of 100.67 in 2024.
- On a YoY basis, Interest Coverage Ratio climbed as much as 98.37% in 2025 and fell as far as 147.91% in 2025.
- Year by year, Interest Coverage Ratio stood at 486.16 in 2024, then slumped by 147.91% to 232.9 in 2025, then jumped by 95.72% to 9.98 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 9.98 in Q1 2026, 232.9 in Q4 2025, and 147.23 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Kura Oncology | 925.97 Mn | 925.97 Mn | 18.00 Mn | -9.98 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.98 |
| Dec 31, 2025 | -232.90 |
| Sep 30, 2025 | -147.23 |
| Jun 30, 2025 | -1.64 |
| Mar 31, 2025 | -161.75 |
| Dec 31, 2024 | 486.16 |
| Sep 30, 2024 | -131.05 |
| Jun 30, 2024 | -100.67 |
| Mar 31, 2024 | -98.05 |
| Dec 31, 2014 | -0.26 |
| Sep 30, 2014 | -2.86 |
| Jun 30, 2014 | -3.19 |
| Mar 31, 2014 | -2.54 |
| Dec 31, 2013 | -4.86 |
| Sep 30, 2013 | -2.69 |
| Jun 30, 2013 | -4.22 |
| Mar 31, 2013 | -3.75 |
| Dec 31, 2012 | -6.51 |
| Sep 30, 2012 | -3.68 |
| Jun 30, 2012 | -3.93 |